According to the recent study the prostate health market is projected to reach an estimated $58.9 billion by 2028 from $38.1 billion in 2023, at a CAGR of 9.1% from 2023 to 2028. Growth in this market is primarily driven by growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.